Composition of the national reserve supply

The national reserve supply is made up as follows.

Item Description Volume Year of purchase Year of expiry Related documents
H5N1 pre-pandemic influenza vaccine The vaccine can reasonably be expected to provide some level of cross-protection against a human H5N1 virus 150,000 courses
(300,000 doses)
2018 2020 National Health Emergency Plan: H5N1 Pre-Pandemic Vaccine Usage Policy
Antiviral medication (Tamiflu and Relenza) Clinically indicated antivirals may shorten the duration and reduce the severity of the symptoms caused by influenza viruses. We store 2 different types of antivirals to provide an alternative for persons who are unable to take one of the medications.   National Health Emergency Plan: National Reserve Supplies
Tamiflu
586,400 courses 2012   2021
263,200 courses   2013 2022
263,200 courses 2014 2024
Relenza
97,148 courses 2016 2026
132,732 courses 2014 2021
Respiratory PPE (Masks) We store 2 different types of masks: P2 and General Purpose    National Health Emergency Plan: National Reserve Supplies
P2 Masks
3,116,000 2016/17  2026/27
1,384,000   2017/18 2027/28
3,973,000 2018/19 2028/29
527,000 2019/20 2029/30
General Purpose masks
4,500,000 2018/19 2028/29
Syringes Syringe supplies adequate to support a pandemic mass vaccination campaign 10.2 million syringes 2017 2022 National Health Emergency Plan: H5N1 Pre-Pandemic Vaccine Usage Policy
Sharps bins Sharps bins supplies adequate to support a pandemic mass vaccination campaign 40,000 sharps bins 2013 No formal expiry date  
Body bags For adverse events and as part of the mass casuality action plan 24,700 2007 No formal expiry date National Health Emergency Plan: Mass casualty action plan
Antibiotics Antibiotics suitable for treatment of bacterial respiratory infections Volume varies by DHB, based on individual DHB requirements 2005–07 Varies by DHB - management of the supply is the responsibility of each DHB National Health Emergency Plan: National Reserve Supplies  
DHB stored PPE Contingency supply of critical clinical supplies, should normal supply chain be disrupted or an increased supply needed due to an adverse event (such as a pandemic) Volume and specific composition varies by DHB, based on individual DHB requirements 2005–07 Varies by DHB – management of the supply is the responsibility of each DHB  
Disposable linen Contingency for adverse event where linen supply chain disrupted 2,000 2013 2016  
2,000 2014 2016
Back to top